Pharmacological Management of Asthma and COPD

Asthma and Chronic Obstructive Pulmonary Disease (COPD) are chronic respiratory conditions that significantly impact the quality of life and long-term health outcomes of patients. This comprehensive CE course for Registered Nurses (RNs) and Nurse Practitioners (NPs) explores the pharmacological management of asthma and COPD, providing up-to-date, evidence-based insights into treatment strategies, diagnostic tools, and patient-centered care approaches.

Participants will gain an in-depth understanding of the pathophysiological mechanisms involved in these conditions, including airway inflammation, immune response, and the role of inflammatory mediators. The course further covers the distinctions between asthma and COPD, classification systems for asthma severity, and diagnostic tools such as spirometry and peak expiratory flow measurement.

Practical modules encompass pharmacological treatment regimens, including bronchodilators, corticosteroids, and combination therapies, as well as non-pharmacological interventions such as lifestyle modification and pulmonary rehabilitation. Additionally, nurses and NPs will learn how to identify acute exacerbations, implement immediate intervention strategies, and tailor ongoing treatment plans to individual patient needs.

By completing this course, learners will enhance their clinical decision-making skills, meet state-mandated CE requirements, and improve patient outcomes in diverse care settings.

Educational Objectives

• Describe the underlying inflammatory mechanisms and airway changes associated with asthma and COPD.
• Differentiate between asthma and COPD in terms of clinical features, triggers, and response to treatment.
• Explain the use of diagnostic tools such as spirometry and peak expiratory flow meters in evaluating respiratory conditions.
• Implement individualized, evidence-based pharmacological and non-pharmacological treatment plans for asthma and COPD.
• Recognize signs and symptoms of acute exacerbations and initiate appropriate emergency interventions to manage respiratory distress.

Who Should Do This Course

This CE activity is intended for Registered Nurses (RNs) and Nurse Practitioners (NPs) involved in primary care, pulmonary medicine, emergency care, and chronic disease management. It is especially suitable for nurses seeking to fulfill state-mandated license renewal requirements in advanced pharmacology, pharmacotherapeutics, or general pharmacology.

This course meets the continuing education requirements in the following states:

• Advanced Pharmacology – Nursing: Ohio, Alaska
• Pharmacotherapeutics – Nursing: Hawaii, Louisiana, Oklahoma, West Virginia, Connecticut, Arkansas, Illinois, Nebraska, South Carolina, Texas, Washington, Wisconsin
• Pharmacology – Nursing: Alabama, Indiana

Did You Know?

• Asthma affects more than 25 million people in the U.S., including 5.1 million children. (CDC)
• COPD is the fourth leading cause of death in the United States, accounting for more than 150,000 deaths annually. (American Lung Association)
• Inappropriate inhaler technique is responsible for poor asthma control in up to 70% of cases. (NIH)
• Early treatment and patient education can reduce hospital admissions for COPD exacerbations by 40%. (GOLD Report)